The role of peripheral input for chronic pain syndromes like fibromyalgia syndrome

Journal of Musculoskeletal Pain

Volumn 16, Issue 1-2, 2008, Pages 67-74

  Staud, Roland ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic pain; Fibromyalgia syndrome; Nociception

Indexed keywords

ALLODYNIA; CHRONIC PAIN; FIBROMYALGIA; HUMAN; HYPERALGESIA; MICROCIRCULATION; MYALGIA; PATHOGENESIS; REVIEW; TRIGGER POINT;

EID: 67949109616     PISSN: 10582452     EISSN: 15407012     Source Type: Journal    
DOI: 10.1080/10582450801960339     Document Type: Review

References (84)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 33: 160-172, 1990.
2. Sarzi-Puttini P, Atzeni F, Diana A, Doria A, Furlan R: Increased neural sympathetic activation in fibromyalgia syndrome. Ann N Y Acad Sci 1069: 109-117, 2006.
3. Crofford LJ: The relationship of fibromyalgia to neuropathic pain syndromes. J Rheumatol (Suppl) 75: 41-45, 2005.
4. Gerwin RD: A review of myofascial pain and fibromyalgia - factors that promote their persistence. Acupuncture in Medicine 23: 121-134, 2005.
5. Adler GK, Kinsley BT, Hurwitz S, Mossey CJ, Goldenberg DL: Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 106: 534-543, 1999.
6. Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR: Responses of the sympathetic nervous system and the hypothalamic-pituitary- adrenal axis to interleukin-6 - A pilot study in fi-bromyalgia. Arthritis Rheum 43: 872-880, 2000.
7. Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, Lopez Y, MacKillip F: Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 37: 1593-1601, 1994.
8. Bradley LA, Alarcon GS, Sotolongo A, Weigent DA, Alberts KR, Blalock JE, Kersh BC, Domino ML, De Waal D: Cerebrospinal fluid (CSF) levels of substance P (SP) are abnormal in patients with fibromyalgia (FMS) regardless of traumatic or insidious pain onset. Arthritis Rheum 41: S256, 1998.
9. Vaeroy H, Helle R, Forre O, Kass E, Terenius L: Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: New features for diagnosis. Pain 32: 21-26, 1988.
10. Neeck G: Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients. Scand J Rheumatol 29: 8-12, 2000.
11. Giovengo SL, Russell IJ, Larson AA: Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol 26: 1564-1569, 1999.
12. Lewin GR, Mendell LM: Nerve growth factor and nociception. Trends Neurosci 16: 353-359, 1993.
13. Petty BG, Cornblath DR, Adornato BT, Chaudhry V, Flexner C, Wachsman M, Sinicropi D, Burton LE, Peroutka SJ: The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 36: 244-246, 1994.
14. Fu KY, Light AR, Maixner W: Long-lasting inflammation and long-term hyperalgesia after subcutaneous formalin injection into the rat hindpaw. J Pain 2: 2-11, 2001.
15. Wallace DJ, Linker-Israeli M, Hallegua D, Silver-man S, Silver D, Weisman MH: Cytokines play an aetiopathogenetic role in fibromyalgia: A hypothesis and pilot study. Rheumatology 40: 743-749, 2001.
16. Salemi S, Rethage J, Wollina U, Michel BA, Gay RE, Gay S, Sprott H: Detection of interleukin 1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. J Rheumatol 30: 146-150, 2003.
17. Cunha FQ, Lorenzetti BB, Poole S, Ferreira SH: Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol 104: 765-767, 1991.
18. Henriksson KG: Is fibromyalgia a distinct clinical entity? Pain mechanisms in fibromyalgia syndrome. A myologist's view. Best Pract Res Clin Rheumatol 13: 455-461, 1999.
19. Henriksson KG: Fibromyalgia - From syndrome to disease. Overview of pathogenetic mechanisms. J Rehabil Med 35: 89-94, 2003.
20. Mense S: Nociception from skeletal muscle in relation to clinical muscle pain. Pain 54: 241-289, 1993.
21. Mense S, Schmidt RF: Muscle pain: Which receptors are responsible for the transmission of noxious stimuli? Physiological Aspects of Clinical Neurology. Edited by FC Rose. Blackwell Scientific Publications, Oxford, 1976, pp. 265-278.
22. Mense S: Considerations concerning the neurobiological basis of muscle pain. Can J Physiol Pharmacol 69: 610-616, 1991.
23. Mense S: The pathogenesis of muscle pain. Curr Pain Headache Rep 7: 419-425, 2003.
24. Lautenschlager J, Bruckle W, Schnorrenberger CC, Muller W: Measuring pressure pain of tendons and muscles in healthy probands and patients with generalized tendomyopathy (fibromyalgia syndrome). Z Rheumatol 47: 397-404, 1988.
25. Quimby LG, Block SR, Gratwick GM: Fi-bromyalgia: generalized pain intolerance and manifold symptom reporting. J Rheumatol 15: 1264-1270, 1988.
26. Tunks E, Crook J, Norman G, Kalaher S: Tender points in fibromyalgia. Pain 34: 11-19, 1988.
27. Mikkelsson M, Latikka P, Kautiainen H, Isomeri R, Isomaki H: Muscle and bone pressure pain threshold and pain tolerance in fibromyalgia patients and controls. Arch Phys Med Rehabil 73: 814-818, 1992.
28. Kosek E, Ekholm J, Hansson P: Increased pressure pain sensibility in fibromyalgia patients is located deep to the skin but not restricted to muscle tissue. Pain 63: 335-339, 1995.
29. Bendtsen L, Norregaard J, Jensen R, Olesen J: Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum 40: 98-102, 1997.
30. Vierck CJ, Cannon RL, Fry G, Maixner W, Whitsel BL: Characteristicsoftemporal summationofsecond pain sensations elicited by brief contact of glabrous skin by a preheated thermode. J Neurophysiol 78: 992-1002, 1997.
31. Hokfelt T, Zhang X, Su X, Wiesenfeld-Hallin Z: Central consequences of peripheral nerve damage. Wall and Melzack's Textbook of Pain. Edited by S McMahon, M Koltzenburg. Elsevier, London, 2005, pp. 947-959.
32. Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD: Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 91: 165-175, 2001.
33. Staud R, Cannon RC, Mauderli AP, Robinson ME, Price DD, Vierck CJ: Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain 102: 87-95, 2003.
34. Desmeules JA, Cedraschi C, Rapiti E, Baumgartner E, Finckh A, Cohen P, Dayer P, Vischer TL: Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 48: 1420-1429, 2003.
35. Sorensen J, Graven-Nielsen T, Henriksson KG, Bengtsson M, Arendt-Nielsen L: Hyperexcitability in fibromyalgia. J Rheumatol 25: 152-155, 1998.
36. Kosek E, Ekholm J, Hansson P: Modulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls. Pain 64: 415-423, 1996.
37. Hansson P, Ekblom A, Lindblom U, Marchettini P: Does acute intraoral pain alter cutaneous sensibility? J Neurol Neurosurg Psychiatry 51: 1032-1036, 1988.
38. MaixnerW,FillingimR,BookerD, Sigurdsson A: Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain 63: 341-351, 1995.
39. Curatolo M, Petersen-Felix S, Arendt-Nielsen L, Giani C, Zbinden AM, Radanov BP: Central hypersensitivity in chronic pain after whiplash injury. Clin J Pain 17: 306-315, 2001.
40. Okifuji A, Turk DC: Stress and psychophysiological dysregulation in patients with fibromyalgia syndrome. Appl Psychophysiol Biofeedback 27: 129-141, 2002.
41. Lapossy E, Maleitzke R, Hrycaj P, Mennet W, Muller W: The frequency of transition of chronic low back pain to fibromyalgia. Scand J Rheumatol 24: 29-33, 1995.
42. Bajaj P, Bajaj P, Madsen H, Moller M, Arendt-Nielsen L: Antenatal women with or without pelvic pain can be characterized by generalized or segmen-tal hypoalgesia in late pregnancy. J Pain 3: 451-460, 2002.
43. Ushida T, Willis WD: Changes in dorsal horn neuronal responses in an experimental wrist contracture model. J Orthop Sci 6: 46-52, 2001.
44. Hoheisel U, Koch K, Mense S: Functional reorganization in the rat dorsal horn during an experimental myositis. Pain 59: 111-118, 1994.
45. Price DD, McHaffie JG, Larson MA: Spatial summation of heat-induced pain: Influence of stimulus area and spatial separation of stimuli on perceived pain sensation intensity and unpleasantness. J Neurophysiol 62: 1270-1279, 1989.
46. Staud R, Vierck CJ, Robinson ME, Price DD: Spatial summation of heat pain within and across dermatomes in fibromyalgia patients and pain-free subjects. Pain 111: 342-350, 2004.
47. Julien N, Goffaux P, Arsenault P, Marchand S: Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114: 295-302, 2005.
48. Herren-Gerber R, Weiss S, Arendt-Nielsen L, Petersen-Felix S, Stefano GD, Radanov BP, Curatolo M: Modulation of central hypersensitivity by nociceptive input in chronic pain after whiplash injury. Pain Med 5: 366-376, 2004.
49. Verne GN, Robinson ME, Vase L, Price DD: Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain 105: 223-230, 2003.
50. Sluka KA, Kalra A, Moore SA: Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 24: 37-46, 2001.
51. Sluka KA, Price MP, Breese NA, Stucky CL, Wemmie JA, Welsh MJ: Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1. Pain 106: 229-239, 2003.
52. Elvin A, Siosteen AK, Nilsson A, Kosek E: Decreased muscle blood flow in fibromyalgia patients during standardised muscle exercise: A contrast media enhanced colour Doppler study. Eur J Pain 10: 137-144, 2006.
53. Larsson SE, Alund M, Cai H, Oberg PA: Chronic pain after soft-tissue injury of the cervical spine: Trapezius muscle blood flow and electromyography at static loads and fatigue. Pain 57: 173-180, 1994.
54. Bennett RM, Clark SR, Goldberg L, Nelson D, Bonafede RP, Porter J, Specht D: Aerobic fitness in patients with fibrositis. A controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle. Arthritis Rheum 32: 454-460, 1989.
55. Lund N, Bengtsson A, Thorborg P: Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 15: 165-173, 1986.
56. Strobel ES, Krapf M, Suckfull M, Bruckle W, Fleckenstein W, Muller W: Tissue oxygen measurement and 31P magnetic resonance spectroscopy in patients with muscle tension and fibromyalgia. Rheumatol Int 16: 175-180, 1997.
57. Bengtsson A, Henriksson KG, Larsson J: Muscle biopsyin primary fibromyalgia. Light-microscopical and histochemical findings. Scand J Rheumatol 15: 1-6, 1986.
58. Lindh M, Johansson G, Hedberg M, Henning GB, Grimby G: Muscle fiber characteristics, capillaries and enzymes in patients with fibromyalgia and controls. Scand J Rheumatol 24: 34-37, 1995.
59. Lindman R, Hagberg M, Bengtsson A, Henriksson KG, Thornell LE: Capillary structure and mitochondrial volume density in the trapezius muscle of chronic trapezius myalgia, fibromyalgia and healthy subjects. J Musculoskelet Pain 3: 5-22, 1995.
60. Bengtsson A, Bengtsson M: Regional sympathetic blockade in primary fibromyalgia. Pain 33: 161-167, 1988.
61. Mense S, Stahnke M: Responses in muscle afferent fibres of slow conduction velocity to contractions and ischaemia in the cat. J Physiol 342: 383-397, 1983.
62. Qiao ZG, Vaeroy H, Morkrid L: Electrodermal and microcirculatory activity in patients with fibromyalgia during baseline, acoustic stimulation and cold pressor tests. J Rheumatol 18: 1383-1389, 1991.
63. Mengshoel AM, Vollestad NK, Forre O: Pain and fatigue induced by exercise in fibromyalgia patients and sedentary healthy subjects. Clin Exp Rheumatol 13: 477-482, 1995.
64. Vierck CJ, Staud R, Price DD, Cannon RL, Mauderli AP, Martin AD: The effect of maximal exercise on temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. J Pain 2: 334-344, 2001.
65. Buskila D, Neumann L, Vaisberg G, Alkalay D, Wolfe F: Increased rates of fibromyalgia following cervical spine injury. A controlled study of 161 cases of traumatic injury. Arthritis Rheum 40: 446-452, 1997.
66. Neumann L, Zeldets V, Bolotin A, Buskila D: Outcome of posttraumatic fibromyalgia: A 3-year follow-up of 78 cases of cervical spine injuries. Semin Arthritis Rheum 32: 320-325, 2003.
67. Sorensen J, Bengtsson A, Ahlner J, Henriksson KG, Ekselius L, Bengtsson M: Fibromyalgia - are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol 24: 1615-1621, 1997.
68. Graven-Nielsen T, Aspegren KS, Henriksson KG, Bengtsson M, Sorensen J, Johnson A, Gerdle B, ArendtNielsen L: Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 85: 483-491, 2000.
69. Berglund B, Harju EL, Kosek E, Lindblom U: Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia. Pain 96: 177-187, 2002.
70. Granot M, Buskila D, Granovsky Y, Sprecher E, Neumann L, Yarnitsky D: Simultaneous recording of late and ultra-late pain evoked potentials in fibromyalgia. Clinical Neurophysiology 112: 1881-1887, 2001.
71. Lorenz J, Grasedyck K, Bromm B: Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome. Electroencephalogr Clin Neurophysiol 100: 165-168, 1996.
72. Lautenbacher S, Rollman GB: Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 13: 189-196, 1997.
73. Yunus MB: Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J Rheumatol 19: 846-850, 1992.
74. Granges G, Littlejohn G: Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 36: 642-646, 1993.
75. Staud R, Price DD, Robinson ME, Mauderli AP, Vierck CJ: Maintenance of windup of second pain requires less frequent stimulation in fibromyalgia patients compared to normal controls. Pain 110: 689-696, 2004.
76. Arendt-NielsenL, Graven-NielsenT: Central sen-sitization in fibromyalgia and other musculoskeletal disorders. Curr Pain Headache Rep 7: 355-361, 2003.
77. Gracely RH, Petzke F, Wolf JM, Clauw DJ: Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46: 1333-1343, 2002.
78. Cook DB, Lange G, Ciccone DS, Liu WC, Steffener J, Natelson BH: Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 31: 364-378, 2004.
79. Kong J, White NS, Kwong KK, Vangel MG, Rosman IS, Gracely RH, Gollub RL: Using FMSRI to dissociate sensory encoding from cognitive evaluation of heat pain intensity. Hum Brain Mapp 27: 715-721, 2006.
80. Bengtsson A, Henriksson KG, Larsson J: Muscle biopsyin primary fibromyalgia. Light-microscopical and histochemical findings. Scan J Rheumatol 15: 1-6, 1986.
81. Bartels EM, nneskiold-Samsoe B: Histological abnormalities in muscle from patients with certain types of fibrositis. Lancet 1: 755-757, 1986.
82. Kalyan-RamanUP,Kalyan-RamanK,YunusMB, Masi AT: Muscle pathology in primary fibromyalgia syndrome: A light microscopic, histochemical and ultrastructural study. J Rheumatol 11: 808-813, 1984.
83. Pongratz DE, Spath M: Morphologic aspects of fibromyalgia. Z Rheumatol 57: 47-51, 1998.
84. Drewes AM, AndreasenA,Schroder HD, Hogsaa B, Jennum P: Pathology of skeletal muscle in fibromyalgia: A histo-immuno-chemical and ultrastructural study. Br J Rheumatol 32: 479-483, 1993.